US Stock MarketDetailed Quotes

UTMD Utah Medical Products

Watchlist
  • 66.780
  • -0.280-0.42%
Close Jun 14 16:00 ET
  • 66.780
  • 0.0000.00%
Post 16:05 ET
235.63MMarket Cap14.84P/E (TTM)

Utah Medical Products Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-9.42%11.34M
-3.93%50.22M
-9.14%12.33M
-3.47%12.51M
-4.19%12.87M
1.60%12.52M
6.58%52.28M
5.11%13.57M
3.05%12.96M
6.54%13.43M
Operating revenue
-9.42%11.34M
-3.93%50.22M
-9.14%12.33M
-3.47%12.51M
-4.19%12.87M
1.60%12.52M
6.58%52.28M
5.11%13.57M
3.05%12.96M
6.54%13.43M
Cost of revenue
-2.20%4.57M
0.50%20.19M
-0.23%5.24M
7.91%5.15M
-2.84%5.13M
-2.36%4.68M
10.74%20.09M
9.29%5.25M
6.00%4.77M
9.50%5.28M
Gross profit
-13.73%6.77M
-6.70%30.04M
-14.76%7.1M
-10.10%7.36M
-5.05%7.74M
4.12%7.84M
4.14%32.2M
2.64%8.33M
1.40%8.19M
4.70%8.15M
Operating expense
-28.58%2.14M
6.89%13.26M
-3.16%3.15M
11.33%3.39M
7.11%3.31M
-0.53%3M
3.07%12.41M
9.19%3.26M
2.35%3.05M
2.45%3.09M
Selling and administrative expenses
8.39%1.37M
6.61%12.7M
-4.02%3.01M
10.88%3.25M
7.50%3.18M
-56.27%1.26M
3.49%11.91M
10.27%3.13M
2.98%2.93M
2.32%2.96M
-Selling and marketing expense
6.46%412K
11.81%1.69M
----
----
----
--387K
6.58%1.51M
----
----
----
-General and administrative expense
9.25%957K
5.86%11.02M
----
----
----
--876K
3.06%10.41M
----
----
----
Research and development costs
84.72%266K
13.59%560K
18.70%146K
23.21%138K
-1.48%133K
17.07%144K
-6.27%493K
-12.77%123K
-11.81%112K
5.47%135K
Depreciation amortization depletion
-68.26%504K
----
----
----
----
--1.59M
----
----
----
----
-Depreciation and amortization
-68.26%504K
----
----
----
----
--1.59M
----
----
----
----
Operating profit
-4.56%4.63M
-15.22%16.78M
-22.21%3.94M
-22.80%3.97M
-12.50%4.43M
7.21%4.85M
4.82%19.79M
-1.17%5.07M
0.84%5.14M
6.13%5.06M
Net non-operating interest income expense
Other net income (expense)
-36.53%172K
281.13%3.31M
105.95%1.07M
310.10%812K
426.06%747K
3,287.50%271K
380.11%869K
921.57%521K
235.59%198K
136.67%142K
Gain on sale of security
----
359.30%3.04M
----
----
----
----
298.19%661K
----
----
----
Special income (charges)
-81.66%-743K
----
----
----
----
---409K
----
----
----
----
-Less:Other special charges
81.66%743K
----
----
----
----
--409K
----
----
----
----
Other non- operating income (expenses)
34.56%915K
32.69%276K
-1,302.14%-1.96M
310.10%812K
426.06%747K
8,400.00%680K
1,286.67%208K
-21.74%-140K
235.59%198K
136.67%142K
Income before tax
-6.27%4.8M
-2.76%20.09M
-10.27%5.02M
-10.45%4.78M
-0.52%5.17M
13.00%5.12M
8.38%20.66M
7.91%5.59M
3.53%5.34M
7.75%5.2M
Income tax
-6.96%842K
-17.49%3.45M
-29.44%731K
-20.11%846K
-11.31%972K
-9.14%905K
-2.04%4.19M
-1.24%1.04M
11.36%1.06M
-21.66%1.1M
Net income
-6.12%3.96M
0.98%16.64M
-5.91%4.29M
-8.06%3.94M
2.36%4.2M
19.24%4.21M
11.39%16.47M
10.24%4.56M
1.76%4.28M
19.76%4.1M
Net income continuous Operations
-6.12%3.96M
0.98%16.64M
-5.91%4.29M
-8.06%3.94M
2.36%4.2M
19.24%4.21M
11.39%16.47M
10.24%4.56M
1.76%4.28M
19.76%4.1M
Minority interest income
Net income attributable to the parent company
-6.12%3.96M
0.98%16.64M
-5.91%4.29M
-8.06%3.94M
2.36%4.2M
19.24%4.21M
11.39%16.47M
10.24%4.56M
1.76%4.28M
19.76%4.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.12%3.96M
0.98%16.64M
-5.91%4.29M
-8.06%3.94M
2.36%4.2M
19.24%4.21M
11.39%16.47M
10.24%4.56M
1.76%4.28M
19.76%4.1M
Basic earnings per share
-6.03%1.09
1.10%4.58
-5.94%1.181
-8.47%1.08
2.65%1.16
19.59%1.16
11.85%4.53
11.08%1.2555
2.61%1.18
20.21%1.13
Diluted earnings per share
-6.03%1.09
1.11%4.57
-5.83%1.18
-8.47%1.08
2.68%1.15
20.83%1.16
11.88%4.52
11.18%1.253
2.61%1.18
19.15%1.12
Dividend per share
1.69%0.3
1.72%1.185
1.69%0.3
1.72%0.295
1.72%0.295
1.72%0.295
36.26%1.165
0.295
1.75%0.29
1.75%0.29
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -9.42%11.34M-3.93%50.22M-9.14%12.33M-3.47%12.51M-4.19%12.87M1.60%12.52M6.58%52.28M5.11%13.57M3.05%12.96M6.54%13.43M
Operating revenue -9.42%11.34M-3.93%50.22M-9.14%12.33M-3.47%12.51M-4.19%12.87M1.60%12.52M6.58%52.28M5.11%13.57M3.05%12.96M6.54%13.43M
Cost of revenue -2.20%4.57M0.50%20.19M-0.23%5.24M7.91%5.15M-2.84%5.13M-2.36%4.68M10.74%20.09M9.29%5.25M6.00%4.77M9.50%5.28M
Gross profit -13.73%6.77M-6.70%30.04M-14.76%7.1M-10.10%7.36M-5.05%7.74M4.12%7.84M4.14%32.2M2.64%8.33M1.40%8.19M4.70%8.15M
Operating expense -28.58%2.14M6.89%13.26M-3.16%3.15M11.33%3.39M7.11%3.31M-0.53%3M3.07%12.41M9.19%3.26M2.35%3.05M2.45%3.09M
Selling and administrative expenses 8.39%1.37M6.61%12.7M-4.02%3.01M10.88%3.25M7.50%3.18M-56.27%1.26M3.49%11.91M10.27%3.13M2.98%2.93M2.32%2.96M
-Selling and marketing expense 6.46%412K11.81%1.69M--------------387K6.58%1.51M------------
-General and administrative expense 9.25%957K5.86%11.02M--------------876K3.06%10.41M------------
Research and development costs 84.72%266K13.59%560K18.70%146K23.21%138K-1.48%133K17.07%144K-6.27%493K-12.77%123K-11.81%112K5.47%135K
Depreciation amortization depletion -68.26%504K------------------1.59M----------------
-Depreciation and amortization -68.26%504K------------------1.59M----------------
Operating profit -4.56%4.63M-15.22%16.78M-22.21%3.94M-22.80%3.97M-12.50%4.43M7.21%4.85M4.82%19.79M-1.17%5.07M0.84%5.14M6.13%5.06M
Net non-operating interest income expense
Other net income (expense) -36.53%172K281.13%3.31M105.95%1.07M310.10%812K426.06%747K3,287.50%271K380.11%869K921.57%521K235.59%198K136.67%142K
Gain on sale of security ----359.30%3.04M----------------298.19%661K------------
Special income (charges) -81.66%-743K-------------------409K----------------
-Less:Other special charges 81.66%743K------------------409K----------------
Other non- operating income (expenses) 34.56%915K32.69%276K-1,302.14%-1.96M310.10%812K426.06%747K8,400.00%680K1,286.67%208K-21.74%-140K235.59%198K136.67%142K
Income before tax -6.27%4.8M-2.76%20.09M-10.27%5.02M-10.45%4.78M-0.52%5.17M13.00%5.12M8.38%20.66M7.91%5.59M3.53%5.34M7.75%5.2M
Income tax -6.96%842K-17.49%3.45M-29.44%731K-20.11%846K-11.31%972K-9.14%905K-2.04%4.19M-1.24%1.04M11.36%1.06M-21.66%1.1M
Net income -6.12%3.96M0.98%16.64M-5.91%4.29M-8.06%3.94M2.36%4.2M19.24%4.21M11.39%16.47M10.24%4.56M1.76%4.28M19.76%4.1M
Net income continuous Operations -6.12%3.96M0.98%16.64M-5.91%4.29M-8.06%3.94M2.36%4.2M19.24%4.21M11.39%16.47M10.24%4.56M1.76%4.28M19.76%4.1M
Minority interest income
Net income attributable to the parent company -6.12%3.96M0.98%16.64M-5.91%4.29M-8.06%3.94M2.36%4.2M19.24%4.21M11.39%16.47M10.24%4.56M1.76%4.28M19.76%4.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.12%3.96M0.98%16.64M-5.91%4.29M-8.06%3.94M2.36%4.2M19.24%4.21M11.39%16.47M10.24%4.56M1.76%4.28M19.76%4.1M
Basic earnings per share -6.03%1.091.10%4.58-5.94%1.181-8.47%1.082.65%1.1619.59%1.1611.85%4.5311.08%1.25552.61%1.1820.21%1.13
Diluted earnings per share -6.03%1.091.11%4.57-5.83%1.18-8.47%1.082.68%1.1520.83%1.1611.88%4.5211.18%1.2532.61%1.1819.15%1.12
Dividend per share 1.69%0.31.72%1.1851.69%0.31.72%0.2951.72%0.2951.72%0.29536.26%1.1650.2951.75%0.291.75%0.29
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg